[LGND] YoY Quarter Result on 31-Mar-2013 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- 40.64%
YoY- 31.95%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 29,648 14,602 15,958 11,651 5,636 3,896 5,958 30.63%
PBT 9,571 -74 2,150 1,370 -522 -4,292 -2,715 -
Tax 3,694 15 53 66 -35 -13,778 274 54.21%
NP 6,608 754 2,097 1,495 1,133 9,625 -2,750 -
Tax Rate -38.60% - -2.47% -4.82% - - - -
Total Cost 23,040 13,848 13,861 10,156 4,503 -5,729 8,708 17.58%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin 22.29 5.16 13.14 12.83 20.10 247.05 -46.16 -
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS 0.32 0.04 0.10 0.07 0.07 0.49 -0.14 -
EPS Diluted 0.30 0.04 0.10 0.07 0.07 0.49 -0.14 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.